Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Strong Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

AVROBIO, Inc. Common Stock (AVRO)

Biological Products, (no Disgnostic Substances)

https://www.avrobio.com

Avrobio Inc is a clinical-stage gene therapy company. It is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single dose treatment regimen. The company's pipeline includes AVR-RD-04 for the treatment of cystinosis; AVR-RD-02 for the treatment of Gaucher disease type 1; AVR-RD-05 for the treatment of Hunter syndrome; AVR-RD-06 for the treatment of Gaucher disease type 3; and AVR-RD-03 for the treatment of Pompe disease.

100 TECHNOLOGY SQUARE, 6TH FLOOR
CAMBRIDGE, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/21/2018

Market Cap

5,237,596

Shares Outstanding

44,570,000

Weighted SO

44,573,911

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

CWBR --.--%

OCEA --.--%

ENVB --.--%

ELEV --.--%

ZURA --.--%

HEPA --.--%

EFTR --.--%

Beta

1.2230

Last Div

0.0000

Range

1.38-19.8

Chg

-0.0200

Avg Vol

19048

Mkt Cap

5237596

Exch

NASDAQ

Country

US

Phone

617 914 8420

DCF Diff

-0.7860

DCF

2.1860

Div Yield

0.0000

P/S

1.4557

EV Multiple

1.6414

P/FV

0.7059

Div Yield %

0.0000

P/E

2.0691

PEG

0.0186

Payout

0.0000

Current Ratio

26.1721

Quick Ratio

25.8661

Cash Ratio

25.8661

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

33.1199

CCC

-33.1199

Gross Margin

0.2557

Op Margin

7.7351

Pretax Margin

8.5278

Net Margin

8.4230

Eff Tax Rate

-0.0837

ROA

0.3282

ROE

0.2968

ROCE

0.3133

NI/EBT

0.9877

EBT/EBIT

1.1025

EBIT/Rev

7.7351

Debt Ratio

0.0024

D/E

0.0025

LT Debt/Cap

0.0000

Total Debt/Cap

0.0025

Int Coverage

12.8135

CF/Debt

-225.3348

Equity Multi

1.0395

Rec Turnover

0.0000

Pay Turnover

11.0206

Inv Turnover

0.0000

FA Turnover

32.7091

Asset Turnover

0.0390

OCF/Share

-1.1269

FCF/Share

-1.1269

Cash/Share

2.0264

OCF/Sales

-14.0286

FCF/OCF

1.0000

CF Coverage

-225.3348

ST Coverage

-225.3348

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

0.7059

P/B

0.7059

P/S

1.4557

P/E

2.0691

P/FCF

-0.1038

P/OCF

-1.2423

P/CF

-1.2423

PEG

0.0186

P/S

1.4557

EV Multiple

1.6414

P/FV

0.7059

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation